WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Hard Copy (Hard Back) Information Icon
  • Hard Copy (Hard Back) Information Icon
Live Chat Live Help Software for Website

Handbook of Drug Screening. Edition No. 2. Drugs and the Pharmaceutical Sciences

Informa Healthcare, June 2009, Pages: 504

Building upon the foundation of basics discussed in the previous edition, the Second Edition provides a more in-depth look at the latest methods and technologies of advanced drug screening, an essential function of drug discovery.

With extensively updated content and 21 new chapters, this text examines:

- quality and efficiency of drug target validation and potential drug compound selection
- reducing assay costs and improvement in assay technology
- data quality improvement
- trends in drug discovery
- how drug screening can minimize adverse drug effects
- recent advancements, including: high content screening; protein-protein interactions; high-throughput crystallization; lead optimization; chemoinformatics and microfluidics technologies; target validation by genomics, proteomics, and siRNA; structure-based drug design; automation; and medicinal chemistry

Trends in Drug Discovery. Screening Strategies and Infrastructure in Drug Discovery. Logistics in Progression of Compounds to Clinical Development. Assay Technologies in Drug Screening. Proteomics Technologies in Drug Discovery. GPCR Screens. Nuclear Hormone Receptor Screens. Emerging Novel HTS Technologies for Cell Based Assays. In vitro Strategies for Ion Channel Screening in Drug Discovery. Wheat from Chaff: General and Mechanistic Triage of Screening Hits for Enzyme Targets. Protein Kinases and Phosphatases. MicroRNA Strategies in Drug Discovery. Strategies for Screening Biological in Drug Discovery. Cryopreserved Cells in Functional Cell-Based HTS Assays. High Content Screening Assay development. ADME-TOX, PK and Drug Metabolism in Drug Discovery. Compound Management for Drug Screening. Practical Approach to Quantitative High-Throughput Screening. Enabling the Large Scale Analysis of Quantitative High Throughput Screening Data. Nanotechnology in Drug Discovery.

Ramakrishna Seethala Bristol-Meyers Squibb Company, Princeton, New Jersey, USA.

Litao Zhang Bristol-Meyers Squibb, Princeton, New Jersey, USA.

Customers who bought this item also bought